Review article: Interferon and hepatitis C factors predicting therapeutic outcome

C. L. Mabee, J. S. Crippin, W. M. Lee

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations

Abstract

Hepatitis C chronically infects ≃ 1.5% of Americans and is the most common clinical problem facing hepatologists. Since the virus was initially described in 1989, development of an effective therapy has been challenging. Although several different therapeutic agents have been used, no therapy has been shown to reliably eradicate the virus. Interferon-alpha, a cytokine with immunostimulatory and anti-viral properties, has become the therapy of choice for patients with chronic hepatitis C infection. Trials assessing the efficacy of interferon-alpha have characterized host and viral factors predictive of responses to treatment. A thorough understanding of these predictive factors is requisite to providing cost-effective therapeutic decisions for the patient with chronic hepatitis C infection.

Original languageEnglish (US)
Pages (from-to)509-518
Number of pages10
JournalAlimentary Pharmacology and Therapeutics
Volume12
Issue number6
DOIs
StatePublished - 1998

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Review article: Interferon and hepatitis C factors predicting therapeutic outcome'. Together they form a unique fingerprint.

Cite this